Article
Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study.
PloS one - 1 Jan 2023
Wen Meng-Jung, Hsu Han-Lin, Chang Chia-Lun, Wang Jou-Han, Kuo Chun-Nan, Hsin Yen-Chun, Chang Elizabeth H
Abstract excerpt
BACKGROUND AND OBJECTIVE: Patients with cancer taking oral antineoplastic medications may encounter problems including suboptimal adherence as well as physical and psychological disease burden. Despite increase in the use of oncology pharmacy services, there are wide variations between healthcare professionals and patient perceptions of patients' medication experiences. The objective of the study was to explore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
